AbbVie Inc. (ABBV) FY2024 Q3 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2024-09-30

Swipe to see the full flow
AbbVie Inc. (ABBV) FY2024 Q3 Balance SheetBalance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.Current liabilities$43.06 BLiabilities(calculated)$137.35 BCurrent assets$27.79 BAssets$143.42 BNon-current liabilities$94.29 BNon-current assets$115.64 BEquity$6.07 BGross equity(calculated)$21.22 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netCash and equivalentsPrepaid expenses and otherInventoriesShort-term investmentsIntangible assets, netGoodwillOther assetsProperty and equipment, netInvestmentsAccounts payable and accrued liabilitiesCurrent portion of long-term debt and finance lease obligationsLong-term debt and finance lease obligationsOther long-term liabilitiesDeferred income taxesAdditional paid-in capitalCommon stock, $0.01 par value, 4,000,000,000 shares authorized, 1,831,415,039 shares issued as of September 30, 2024 and 1,823,046,087 as of December 31, 2023Noncontrolling interestCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityGross equity (calculated)Common stock held in treasury, at cost, 64,310,426 shares as of September 30, 2024 and 57,105,354 as of December 31, 2023Accumulated deficitAccumulated other comprehensive lossCurrent liabilitiesCurrent liabilities$43.06 BAccounts receivable, netAccounts receivable, net$11.47 BLiabilities (calculated)Liabilities(calculated)$137.35 BCurrent assetsCurrent assets$27.79 BAccounts payable and accrued liabilitiesAccounts payable and accrued liabilities$30.49 BCash and equivalentsCash and equivalents$7.26 BPrepaid expenses and otherPrepaid expenses and other$4.58 BCurrent portion of long-term debt and finance lease obligationsCurrent portion of long-term debtand finance lease obligations$12.57 BAssetsAssets$143.42 BInventoriesInventories$4.45 BNon-current liabilitiesNon-current liabilities$94.29 BShort-term investmentsShort-term investments$28.00 MLong-term debt and finance lease obligationsLong-term debt and finance lease obligations$58.51 BNon-current assetsNon-current assets$115.64 BIntangible assets, netIntangible assets, net$66.65 BOther long-term liabilitiesOther long-term liabilities$33.03 BEquityEquity$6.07 BDeferred income taxesDeferred income taxes$2.75 BGoodwillGoodwill$35.30 BGross equity (calculated)Gross equity(calculated)$21.22 BAdditional paid-in capitalAdditional paid-in capital$21.16 BOther assetsOther assets$8.29 BCommon stock, $0.01 par value, 4,000,000,000 shares authorized, 1,831,415,039 shares issued as of September 30, 2024 and 1,823,046,087 as of December 31, 2023Common stock$18.00 MProperty and equipment, netProperty and equipment, net$5.14 BNoncontrolling interestNoncontrolling interest$39.00 MInvestmentsInvestments$267.00 MCommon stock held in treasury, at cost, 64,310,426 shares as of September 30, 2024 and 57,105,354 as of December 31, 2023Common stock held in treasury−$7.85 BAccumulated deficitAccumulated deficit−$4.96 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$2.33 B
Chart details

AbbVie Inc. (ABBV) FY2024 Q3 Balance Sheet

Balance sheet as of 2024-09-30. The chart shows assets, liabilities and equity at that date.

Assets
143,422,000,000 US dollars
Current assets
27,785,000,000 US dollars
Non-current assets
115,637,000,000 US dollars
Liabilities (calculated)
137,351,000,000 US dollars
Current liabilities
43,062,000,000 US dollars
Non-current liabilities
94,289,000,000 US dollars
Equity
6,071,000,000 US dollars
Noncontrolling interest
39,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Accounts receivable, net
11,472,000,000 US dollars
Cash and equivalents
7,257,000,000 US dollars
Prepaid expenses and other
4,578,000,000 US dollars
Inventories
4,450,000,000 US dollars
Short-term investments
28,000,000 US dollars
Intangible assets, net
66,646,000,000 US dollars
Goodwill
35,295,000,000 US dollars
Other assets
8,288,000,000 US dollars
Property and equipment, net
5,141,000,000 US dollars
Investments
267,000,000 US dollars
Accounts payable and accrued liabilities
30,492,000,000 US dollars
Current portion of long-term debt and finance lease obligations
12,570,000,000 US dollars
Long-term debt and finance lease obligations
58,509,000,000 US dollars
Other long-term liabilities
33,031,000,000 US dollars
Deferred income taxes
2,749,000,000 US dollars
Additional paid-in capital
21,160,000,000 US dollars
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,831,415,039 shares issued as of September 30, 2024 and 1,823,046,087 as of December 31, 2023
18,000,000 US dollars
Noncontrolling interest
39,000,000 US dollars
Common stock held in treasury, at cost, 64,310,426 shares as of September 30, 2024 and 57,105,354 as of December 31, 2023
negative 7,848,000,000 US dollars
Accumulated deficit
negative 4,964,000,000 US dollars
Accumulated other comprehensive loss
negative 2,334,000,000 US dollars
Gross equity (calculated)
21,217,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
AbbVie Inc. (ABBV) FY2024 Q3 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!